New Concept Energy (GBR) Earnings Date, Estimates & Call Transcripts

$1.27
-0.03 (-2.31%)
(As of 05/8/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 8Estimated
Actual EPS
(Apr. 1)
-$0.04 Missed By -$0.04
Skip Charts & View Estimated and Actual Earnings Data

GBR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GBR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

GBR Earnings Date and Information

New Concept Energy last released its earnings data on April 1st, 2024. The reported ($0.04) EPS for the quarter. The business had revenue of $0.04 million for the quarter. New Concept Energy has generated ($0.03) earnings per share over the last year (($0.03) diluted earnings per share). New Concept Energy has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

New Concept Energy Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
4/1/2024Q4 2023-($0.04)($0.04)($0.04)-$0.04 million
11/9/2023Q3 2023-$0.01+$0.01$0.01-$0.04 million
8/7/2023Q2 2023-($0.01)($0.01)($0.01)-$0.04 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
5/10/2023Q1 2023-$0.01+$0.01$0.01-$0.05 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
3/21/2023Q4 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)

Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.

Don't miss out on the "next Ozempic" >>>
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
11/10/2022Q3 2022-$0.01+$0.01$0.01-$0.06 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
8/10/2022Q2 2022-$0.02+$0.02$0.02-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
5/12/2022Q1 2022-$0.01+$0.01$0.01-$0.05 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)

A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.

Don't miss out on the "next Ozempic" >>>
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
3/22/2022Q4 2021-($0.01)($0.01)($0.01)-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
11/10/2021Q3 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
8/13/2021Q2 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)

A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.

Don't miss out on the "next Ozempic" >>>
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million
5/17/2021Q1 2021-$0.01+$0.01$0.01-$0.03 million

New Concept Energy Earnings - Frequently Asked Questions

When is New Concept Energy's earnings date?

New Concept Energy has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on GBR's earnings history.

How much revenue does New Concept Energy generate each year?

New Concept Energy (NYSE:GBR) has a recorded annual revenue of $150,000.00.

How much profit does New Concept Energy generate each year?

New Concept Energy (NYSE:GBR) has a recorded net income of -$20,000.00. GBR has generated -$0.03 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NYSE:GBR) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners